Additional European Equity News
AstraZeneca (AZN LN) - Co. provides an update on Resolute Phase III Trial; Fasenra trial did not meet primary endpoint; will analyse full data set from the trial to further understand results. Elsewhere, Saphnelo self-administration TULIP-SC Phase III trial meets primary endpoint in patients with systemic lupus erythematosus based on an interim analysis. (AstraZeneca)
Barratt Redrow (BDEV LN) - FY25 (GBP): Adj. Pretax 488.3mln (prev. 591.6mln Y/Y), Revenue 5.58bln (prev. 4.17bln Y/Y). Affirms FY26 home completions. Notes that moving into FY26, affordability, uncertainty in macro environment and weak consumer confidence remain challenging. (Newswires)
Games Workshop (GAW LN) - Declared a dividend of 85p. Notes that trading is in line with Q1. (Newswires)
Sodexo (SW FP) / Shell (SHEL LN) - Co’s renew 5-year collaboration for workplace services starting 1 Nov 2025. (Newswires)
STMicroelectronics (STMPA FP) - Co. to advance next-gen chip manufacturing tech with new PLP pilot line. (Newswires)
Thyssenkrupp (TKA GY) upgraded to Hold at DZ Bank
Inditex (ITX SM) upgraded to Buy from Neutral at UBS
17 Sep 2025 - 07:04- EquitiesEU Research- Source: Newsquawk
Subscribe Now to Newsquawk
Click here for a 1 week free trial
Newsquawk provides audio news and commentary for over 15,000professional traders and brokers worldwide. Services include:
- Real-time audio coverage from 0630 to 2200 London time plus Asia-Pac 2200 to 1000 London time
- Teams of analysts covering equities, fixed income, FX, energy, and metals markets
- Real-time scrolling news service with instant analysis
- Daily and weekly pre-market research and calendars
- Video updates covering near-term key risk events & primary trading themes
- One-to-one chat with our expert analysts